Key facts
- This page summarizes Pini Ben-Elazar's Form 3 filing for REGENTIS BIOMATERIALS LTD. (RGNT).
- 0 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 18 Mar 2026, 16:30.
Pini Ben-Elazar - 18 Mar 2026 Form 3 Insider Report for REGENTIS BIOMATERIALS LTD. (RGNT)
- Reporting relationship
- Director
- Issuer ticker
- RGNT
- Reported as of
- 18 Mar 2026
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 18 Mar 2026, 16:30:04 UTC
- Next SEC filing
- 13 Jul 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Pini Ben-Elazar
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Pini Ben-Elazar filed Form 3 for REGENTIS BIOMATERIALS LTD. (RGNT) on 18 Mar 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002114839
Primary reporting owner
Ben-Elazar Pini
- Relationship
- Director
- Address
- C/O REGENTIS BIOMATERIALS LTD., 60 MEDINAT HAYEHUDIM, HERZLIYA, ISRAEL
- Signature
- /s/ Pini Ben-Elazar
- Signature date
- 18 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RGNT
holding
Ordinary Shares, no par value per share
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 128,666
- Date
- 18 Mar 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
RGNT
holding
Derivative
Employee Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 39,295
- Exercise price
- $0.0100
- Footnotes
- F1
RGNT
holding
Derivative
Warrants to purchase ordinary shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 15,831
- Exercise price
- $5.00
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
This option grant is fully vested as of this date.
Footnote F2
The warrants are currently exercisable and have a three year term.